echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Without it, there would be no mRNA new crown vaccine lipid nanoparticle technology ushered in a "renaissance"

    Without it, there would be no mRNA new crown vaccine lipid nanoparticle technology ushered in a "renaissance"

    • Last Update: 2021-05-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today, millions of people in the world have been vaccinated with the new crown vaccine developed based on mRNA technology.


    This process is simple to say, but it is not easy to get mRNA through the cell membrane to reach the inside of the cell.


    Obstacles to overcome for mRNA vaccine success

    Obstacles to overcome for mRNA vaccine success

    The mRNA in the mRNA vaccine encodes the antigenic protein on the surface of the new coronavirus.


    Moreover, the mRNA chain is a long chain macromolecule with a negative charge.


    Lipid Nanoparticles-Carriers for Delivery of mRNA into Cells

    Lipid Nanoparticles-Carriers for Delivery of mRNA into Cells

    ▲Schematic diagram of lipid nanoparticle structure (picture source: reference [3])

    The LNP used in the mRNA COVID-19 vaccine now contains a variety of innovations accumulated by this technology in the past three decades.


    A breakthrough in LNP technology is the use of so-called "ionizable lipids" (ionizable lipids, the green molecules in the picture above).


    On the periphery of LNP, there are also PEGylated lipids modified by polyethylene glycol.


    In addition, LNP also contains cholesterol and other auxiliary lipid molecules to help form the complete structure of LNP.


    ▲A schematic diagram of the mRNA vaccine carried by LNP enters the cell and releases mRNA to guide protein synthesis (picture source: reference [3])

    When LNP touches the cell membrane, it will be swallowed by the cell into the cell to form a vesicle called endosome.


    The "Renaissance" of Lipid Nanoparticle Delivery Technology

    The "Renaissance" of Lipid Nanoparticle Delivery Technology

    Before the mRNA COVID-19 vaccine was widely used, the U.


    The success of Pfizer/BioNTech and Moderna's new crown vaccine has inspired the enthusiasm for further optimization of LNP technology.


    In addition to improving the delivery efficiency of LNP and reducing the toxicity of LNP, targeted delivery to specific tissues and cells in the human body is the next challenge that needs to be overcome in this field.


    Reference materials:

    [1] Without these lipid shells, there would be no mRNA vaccines for COVID-19.


    [2] Let's talk about lipid nanoparticles.


    Note: This article aims to introduce the progress of medical and health research, not to recommend treatment options.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.